Truvestments Capital LLC - Q1 2023 holdings

$188 Million is the total value of Truvestments Capital LLC's 670 reported holdings in Q1 2023. The portfolio turnover from Q4 2022 to Q1 2023 was - .

 Value Shares↓ Weighting
AEE NewAMEREN CORP$133,3861,544
+100.0%
0.07%
HON NewHONEYWELL INTL INC$76,448400
+100.0%
0.04%
AAAU NewGOLDMAN SACHS PHYSICAL GOLDunit$36,4021,862
+100.0%
0.02%
CSQ NewCALAMOS STRATEGIC TOTAL RETU$28,2092,015
+100.0%
0.02%
APLE NewAPPLE HOSPITALITY REIT INC$23,4021,508
+100.0%
0.01%
VHT NewVANGUARD WORLD FDShealth car etf$20,50886
+100.0%
0.01%
VV NewVANGUARD INDEX FDSlarge cap etf$17,93496
+100.0%
0.01%
EIX NewEDISON INTL$16,518234
+100.0%
0.01%
XLI NewSELECT SECTOR SPDR TRsbi int-inds$15,238151
+100.0%
0.01%
AI NewC3 AI INCcl a$14,939445
+100.0%
0.01%
PDM NewPIEDMONT OFFICE REALTY TR IN$12,5071,713
+100.0%
0.01%
IYW NewISHARES TRu.s. tech etf$11,137120
+100.0%
0.01%
AMPY NewAMPLIFY ENERGY CORP NEW$10,3051,500
+100.0%
0.01%
NewMOBILEYE GLOBAL INC$8,654200
+100.0%
0.01%
RCEL NewAVITA MEDICAL INC$9,150655
+100.0%
0.01%
TMDX NewTRANSMEDICS GROUP INC$6,81690
+100.0%
0.00%
ETON NewETON PHARMACEUTICALS INC$7,1151,848
+100.0%
0.00%
PLX NewPROTALIX BIOTHERAPEUTICS INC$8,1483,880
+100.0%
0.00%
AZN NewASTRAZENECA PLCsponsored adr$6,80298
+100.0%
0.00%
VDE NewVANGUARD WORLD FDSenergy etf$6,74059
+100.0%
0.00%
KNSA NewKINIKSA PHARMACEUTICALS LTD$4,810447
+100.0%
0.00%
CPRX NewCATALYST PHARMACEUTICALS INC$6,483391
+100.0%
0.00%
SVRA NewSAVARA INC$5,2902,713
+100.0%
0.00%
EW NewEDWARDS LIFESCIENCES CORP$6,20575
+100.0%
0.00%
PLRX NewPLIANT THERAPEUTICS INC$4,894184
+100.0%
0.00%
EXAS NewEXACT SCIENCES CORP$6,17191
+100.0%
0.00%
PRTA NewPROTHENA CORP PLC$5,235108
+100.0%
0.00%
BDX NewBECTON DICKINSON & CO$6,18925
+100.0%
0.00%
NewGE HEALTHCARE TECHNOLOGIES I$5,08662
+100.0%
0.00%
NewINNOVATE CORP$5,3461,800
+100.0%
0.00%
TMO NewTHERMO FISHER SCIENTIFIC INC$5,1879
+100.0%
0.00%
VNQI NewVANGUARD INTL EQUITY INDEX Fglb ex us etf$4,950122
+100.0%
0.00%
TYG NewTORTOISE ENERGY INFRA CORP$5,498187
+100.0%
0.00%
RAIN NewRAIN ONCOLOGY INC$5,733656
+100.0%
0.00%
DYN NewDYNE THERAPEUTICS INC$5,345464
+100.0%
0.00%
DXCM NewDEXCOM INC$4,64740
+100.0%
0.00%
SEDG NewSOLAREDGE TECHNOLOGIES INC$3,64712
+100.0%
0.00%
NewEVE HLDG INC$2,896400
+100.0%
0.00%
RYU NewINVESCO EXCHANGE TRADED FD Ts&p500 eql utl$3,96935
+100.0%
0.00%
INDI NewINDIE SEMICONDUCTOR INC$3,165300
+100.0%
0.00%
RYTM NewRHYTHM PHARMACEUTICALS INC$3,853216
+100.0%
0.00%
SNDX NewSYNDAX PHARMACEUTICALS INC$4,604218
+100.0%
0.00%
OLMA NewOLEMA PHARMACEUTICALS INC$4,5911,323
+100.0%
0.00%
REPL NewREPLIMUNE GROUP INC$3,885220
+100.0%
0.00%
HAL NewHALLIBURTON CO$1,08134
+100.0%
0.00%
ACET NewADICET BIO INC$2,529439
+100.0%
0.00%
GLYC NewGLYCOMIMETICS INC$2,5922,057
+100.0%
0.00%
FLGT NewFULGENT GENETICS INC$1254
+100.0%
0.00%
ETSY NewETSY INC$5575
+100.0%
0.00%
CURI NewCURIOSITYSTREAM INC$3123
+100.0%
0.00%
C NewCITIGROUP INC$46910
+100.0%
0.00%
CRSP NewCRISPR THERAPEUTICS AGnamen akt$63314
+100.0%
0.00%
BIL NewSPDR SER TRbloomberg 1-3 mo$50
+100.0%
0.00%
PINS NewPINTEREST INCcl a$1646
+100.0%
0.00%
OPEN NewOPENDOOR TECHNOLOGIES INC$2816
+100.0%
0.00%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2023-05-12
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
APPLE INC COM21Q3 20234.3%
PROCTER & GAMBLE CO COM21Q3 20234.0%
NEXTERA ENERGY INC COM21Q3 20233.7%
QUALCOMM INC COM21Q3 20232.8%
MICROSOFT CORP COM21Q3 20232.7%
JOHNSON & JOHNSON COM21Q3 20232.5%
INTEL CORP COM21Q3 20232.8%
IRON MTN INC NEW21Q3 20232.2%
3M COMPANY COM21Q3 20231.9%
AMAZON COM INC COM21Q3 20232.1%

View Truvestments Capital LLC's complete holdings history.

Latest filings
TypeFiled
13F-HR2024-05-14
13F-HR2024-02-14
13F-HR2023-11-13
13F-HR2023-08-10
13F-HR2023-05-12
13F-HR2023-02-14
13F-HR2022-11-15
13F-HR2022-08-09
13F-HR2022-05-02
13F-HR2022-02-14

View Truvestments Capital LLC's complete filings history.

Compare quarters

Export Truvestments Capital LLC's holdings